يعرض 1 - 10 نتائج من 11 نتيجة بحث عن '"piracetam"', وقت الاستعلام: 0.75s تنقيح النتائج
  1. 1
    تقرير

    المصدر: Garry LC, Turner M, Standrge SM. creased levetacetam clearance assocted wh a breakthrough seure a pregnant patnt receg once/day extended-release levetacetam. Pharmacotherapy. 2014 Jul;34(7):e128-32. do 10.1002/phar.1439. Epub 2014 May 7.
    Bansal S, Blalock D, Kebede T, Dean NP, Carpenter JL. Levetacetam versus (fos)phenyto for seure prophylax pedtr patnts wh tracranl hemorrhage. J Neurosurg Pedtr. 2014 Feb;13(2):209-15. do 10.3171/2013.10.PEDS13256. Epub 2013 Nov 29.
    Fang Y, Wu X, Xu L, Tang X, Wang J, Zhu G, Hong Z. Randomed-controlled trls of levetacetam as an adjuncte therapy epepsy of multle seure types. J Cl Neurosc 2014 Jan;21(1):55-62. do 10.1016/j.jocn.2013.01.032. Epub 2013 Nov 11.
    Khan O, CrnC, Wrht C, Crp E, KmanB. Role of travenous levetacetam for acute seure management preterm neonates. Pedtr Neurol. 2013 Nov;49(5):340-3. do 10.1016/j.pedtrneurol.2013.05.008. Epub 2013 Aug 3.
    aba K, Menaker J, Branco BC, Gooch J, Okoye OT, Herrold J, Scalea TM, Dubose J, Demetrdes D. A prospecte multenter comparon of levetacetam versus phenyto for early posttraumat seure prophylax. J Trauma Acute Care Surg. 2013 Mar;74(3):766-71; dcussn 771-3. do 10.1097/TA.0b013e3182826e84.
    Kanemura H, Sano F, Suga K, Aara M. Effects of levetacetam on seure frequency and neuropsychologal paments chdren wh refractory epepsy wh secondary bateral synchrony. Seure. 2013 Jan;22(1):43-7. do 10.1016/j.seure.2012.10.003. Epub 2012 Nov 3.
    L YH, Wang XL, Deng YC, Zhao G. Levetacetam-assocted aggravatn of myoclon seure chdren. Seure. 2012 Dec;21(10):807-9. do 10.1016/j.seure.2012.08.008. Epub 2012 Sep 16.
    JehLE, w A KayyalH, Vadera S, Bgaman W, Najm Levetacetam may favorably affect seure outcome after temporal lobectomy. Epeps. 2012 Jun;53(6):979-86. do 10.1111/j.1528-1167.2012.03453.x. Epub 2012 Mar 29.
    Stebaugh LA, Ldsell CJ, Shutter LA, SzaflarskJP. l EEG predts outcomes a trl of levetacetam vs. fosphenyto for seure preventn. Epepsy Behav. 2012 Mar;23(3):280-4. do 10.1016/j.yebeh.2011.12.005. Epub 2012 Feb 16.
    Auv S, Chhun S, Berqu P, Ponchel E, Delanoë C, Chon C. Aggravatn of absence seure related to levetacetam. Eur J Paedtr Neurol. 2011 Nov;15(6):508-11. do 10.1016/j.ejpn.2011.05.007. Epub 2011 Jun 15.
    Levetiracetam Treatment of Neonatal Seizures: A Multi-Centre Randomized Blinded Controlled Study of the Efficacy of Oral Levetiracetam as First Line Treatment for Neonatal Seizures in China

  2. 2
    تقرير

    المصدر: The Feasibility of Using a Subtherapeutic Dose of Piracetam as a Marker of Adherence to Therapy

  3. 3
    تقرير

    المساهمون: Kyle Kampman, Principal Investigator

    المصدر: Piracetam for Treatment of Cocaine Addiction

  4. 4
    تقرير
  5. 5
    تقرير

    المصدر: Therapeutic Use of Piracetam for Treatment of Patients Suffering From Tardive Dyskinesia: a Double Blind, Placebo-Controlled Crossover Study

  6. 6
    تقرير

    المصدر: Jelic V, Kivipelto M, Winblad B. Clinical trials in mild cognitive impairment: lessons for the future. J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):429-38. doi: 10.1136/jnnp.2005.072926. Epub 2005 Nov 23. Erratum In: J Neurol Neurosurg Psychiatry. 2006 Jul;77(7):892.
    A Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of 9600 and 4800 mg/Day Piracetam Taken for 12 Months by Subjects Suffering From Mild Cognitive Impairment (MCI)

  7. 7
    تقرير

    المصدر: Non-interventional Study on Long-term Application of Galantamine and Nootropics in Patients With Alzheimer's Disease

  8. 8
    تقرير

    المصدر: A Phase III, Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Therapeutic Effect of the Association of L-carnitine and Piracetam as an Adjuvant Therapy in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome

  9. 9
    تقرير

    المصدر: Randomized, Double Blind, Placebo Controlled, Two Parallel Group Study to Evaluate the Efficacy and Safety of Piracetam, 12 g Intravenous (IV) Infusion Within 7 Hour (h) Post Stroke Onset, Followed by 12 g/d for 4 Weeks (IV Ampoules, Oral Solution) and 4.8 g/d for 8 Weeks (Tablets) in Adult Subjects With an Acute Ischemic Middle Cerebral Artery Stroke

  10. 10
    تقرير

    المساهمون: Nurettin Özgür Doğan, Assistant Professor

    المصدر: Scholtz AW, Schwarz M, Baumann W, Klefeldt D, Scholtz HJ. Treatment of verto due to acute unateral vestular loss wh a fed combatn of cnare and denhydrate: a double-bld, randomed, parallel-group clal study. Cl Ther. 2004 Jun;26(6):866-77. do 10.1016/s0149-2918(04)90130-0.
    Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo: A Double Blind Randomized Clinical Trial